IL6 and Huntington disease: Indeed, it has been reported that the activation of Nrf2 by triazole-containing compounds reduced the IL-6, IL-1β, TNFα and chemokine CCL2 levels in microglia, astrocytes and cortical neurons from HD mice, and in the monocytes of patients with HD [173].